| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 234.7 | 192.4 | 340.4 |
| Other income | 22.9 | 13.2 | 12.2 |
| Total income | 257.6 | 205.6 | 352.7 |
| Profit before exceptional items & tax | 87.1 | 53.8 | 147.2 |
| Profit before tax | 87.1 | 53.8 | 147.2 |
| Net profit | 64.3 | 40.2 | 110.1 |
| Operating margin | 33.8% | 26.2% | 41.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -41.60% |
|---|---|
| Net profit, quarter on quarter | +60.00% |
| Revenue, year on year | -31.10% |
BSE results filing, NSE: BLUEJET. Figures extracted from the filing.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹542.95
- Market cap
- ₹9,418 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 40.1×Sector 47.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Annual Report
Blue Jet Healthcare Limited has released its Annual Report for FY 2025-26. The 58th Annual General Meeting is scheduled for September 21, 2026, via video conferencing.
Blue Jet Healthcare Business Update
Blue Jet Healthcare Limited has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. The report details the company's ESG performance and statutory disclosures.
Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare Limited will hold its 58th Annual General Meeting on September 21, 2026. The agenda includes a final dividend recommendation of ₹1.20 per share.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.